AMSTERDAM, January 05 (Reuters): The Dutch government was caught off guard by the approval of the Pfizer-BioNTech vaccine by EU regulators in December and has been unable to start vaccinating due to logist
New Delhi, January 5 (PTI): The health ministry on Tuesday said it is prepared to roll out COVID-19 vaccine within 10 days from date of emergency use authorisation, which was issued on January 3, but noted that
New Delhi, December 7 (IANS): Referring to his recent talks with scientists, Prime Minister Narendra Modi on Monday announced that there would not be much delay in the availability of Covid-19 vaccine in India.
London, December 2 (AP): British regulators have become the first to approve the COVID-19 vaccine developed by American drugmaker Pfizer and Germany's BioNTech for experimental use.
Because trials of the
Reuters
Drugmakers and research centres around the world are working on COVID-19 vaccines, with large global trials of several of the candidates involving tens of thousands of participants well underway.
NEW DELHI, November 23 (Reuters): India's health minister said on Sunday a locally-developed COVID-19 vaccine candidate could complete its final trials in a month or two, raising hopes for a rapid
LONDON, November 19 (Reuters): Results of late-stage trials of University of Oxford's COVID-19 vaccine candidate should definitely be known by Christmas, the chief investigator on the study said on Thu
(Reuters): Pfizer Inc's <PFE.N> experimental COVID-19 vaccine is more than 90% effective based on initial trial results, the drugmaker said on Monday, a major victory in the war against a virus t
LONDON, November 4 (Reuters): The University of Oxford hopes to present late-stage trial results on its COVID-19 vaccine candidate this year, raising hopes that Britain could start to roll out a successful
CHICAGO, October 30 (Reuters): If all goes well, the first doses of a safe and effective coronavirus vaccine will likely become available to some high-risk Americans in late December or early January, Dr.
LONDON, October 29 (Reuters): Growing evidence that COVID-19 antibody levels can wane swiftly after someone is infected is not necessarily bad news for immunity, experts said on Thursday, and does not
MOSCOW, October 29 (Reuters): Russia has temporarily stopped vaccinating new volunteers in its COVID-19 vaccine trial due to high demand and a shortage of doses, a representative at the firm running the study s
BRUSSELS, October 29 (Reuters): A vaccine scheme co-led by the World Health Organization is setting up a compensation fund for people in poor nations who might suffer any side-effects from COVID-19 vaccine
Reuters
Moderna Inc is on track to report early data from a late-stage trial of its COVID-19 vaccine candidate next month, the company said on Thursday, offering the clearest timeline yet on when the world w
PARIS, October 28 (Reuters): French drugmaker Sanofi and Britain's GlaxoSmithKline will supply 200 million doses of their COVID-19 candidate vaccine to a global inoculation scheme backed by the Wo
LONDON, October 25 (Reuters): U.S. infectious disease expert Anthony Fauci said on Sunday it would be clear whether a COVID-19 vaccine was safe and effective by early December, but that more widespread vac
MOSCOW, October 17 (Reuters): The Russian Direct Investment Fund (RDIF) and Dr Reddy's Laboratories Ltd have received renewed approval to conduct late-stage clinical trials in India of the Russian COVI
BEIJING, October 17 (Reuters): A Chinese city is offering Sinovac Biotech's <SVA.O> experimental COVID-19 vaccine to essential workers and other high-risk groups as part of a national programme f
New Delhi, October 17 (IANS): The Drug Controller General of India (DCGI) has granted approval to Dr Reddy's, a global pharmaceutical company headquartered in India, to conduct phase 2 and 3 clinical human
GENEVA, October 6 (Reuters): A vaccine against COVID-19 may be ready by year-end, the head of the World Health Organization (WHO) said on Tuesday, without elaborating.
WHO Director-General Tedros Adhano